PLA2 (group IIA phospholipase A2) as a prognostic determinant in stage II colorectal carcinoma



: Buhmeida A, Bendardaf R, Hilska M, Laine J, Collan Y, Laato M, Syrjanen K, Pyrhonen S

Publisher: OXFORD UNIV PRESS

: 2009

 Annals of Oncology

: ANNALS OF ONCOLOGY

: ANN ONCOL

: 20

: 7

: 1230

: 1235

: 6

: 0923-7534

DOI: https://doi.org/10.1093/annonc/mdn783


Conclusions: Quantification of PLA2 expression seems to provide valuable prognostic information in stage II CRC, particularly in selecting the patients at high risk for recurrent disease who might benefit from adjuvant therapy.



Last updated on 14/10/2025 10:15:20 AM